Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients: Results From a Study of Patients Carrying Gene Mutations.
暂无分享,去创建一个
M. Horie | K. Hayashi | M. Yamagishi | M. Kawashiri | H. Tada | H. Ino | H. Itoh | T. Konno | T. Tsuda | Yoshihiro Tanaka | N. Fujino | K. Ohta | Y. Fujii | Y. Tanaka | Takekatsu Saito | Yoko Imi-Hashida
[1] Qing Huang,et al. Diagnostic accuracy of high resolution melting analysis for detection of KRAS mutations: a systematic review and meta-analysis , 2014, Scientific Reports.
[2] K. Hayashi,et al. Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects , 2014, Heart and Vessels.
[3] C. Tracy,et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.
[4] Michael J Ackerman,et al. Impact of genetics on the clinical management of channelopathies. , 2013, Journal of the American College of Cardiology.
[5] P. Schwartz,et al. QTc behavior during exercise and genetic testing for the long-QT syndrome. , 2011, Circulation.
[6] M. Ackerman,et al. The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. , 2011, Heart rhythm.
[7] K. Hayashi,et al. Long QT syndrome and associated gene mutation carriers in Japanese children: results from ECG screening examinations. , 2009, Clinical science.
[8] D. Tester,et al. Congenital Long QT Syndrome , 2008 .
[9] P. Schwartz. The congenital long QT syndromes from genotype to phenotype: clinical implications , 2006, Journal of internal medicine.
[10] D. Tester,et al. Effect of clinical phenotype on yield of long QT syndrome genetic testing. , 2005, Journal of the American College of Cardiology.
[11] D. Roden. Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.
[12] Carlo Napolitano,et al. Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.
[13] S. Priori,et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. , 2003, Journal of the American College of Cardiology.
[14] W. Shimizu,et al. Exercise Stress Test Amplifies Genotype-Phenotype Correlation in the LQT1 and LQT2 Forms of the Long-QT Syndrome , 2003, Circulation.
[15] W. Shen,et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. , 2002, Mayo Clinic proceedings.
[16] K. Hayashi,et al. Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome. , 2002, Cardiovascular research.
[17] S. Priori,et al. Low penetrance in the long-QT syndrome: clinical impact. , 1999, Circulation.
[18] Peter J. Schwartz,et al. Diagnostic Criteria for the Long QT Syndrome An Update , 1993, Circulation.
[19] A. Moss,et al. The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.
[20] G. Vincent,et al. Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome. , 1991, The American journal of cardiology.
[21] P. Schwartz,et al. Idiopathic long QT syndrome: progress and questions. , 1985, American heart journal.